KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Calumet (CLMT) EBIT (2023 - 2025)

Historic EBIT for Calumet (CLMT) over the last 3 years, with Q3 2025 value amounting to $322.9 million.

  • Calumet's EBIT rose 66549.91% to $322.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $195.9 million, marking a year-over-year increase of 78736.84%. This contributed to the annual value of $8.1 million for FY2024, which is 9696.86% down from last year.
  • According to the latest figures from Q3 2025, Calumet's EBIT is $322.9 million, which was up 66549.91% from -$101.0 million recorded in Q2 2025.
  • Calumet's 5-year EBIT high stood at $322.9 million for Q3 2025, and its period low was -$101.0 million during Q2 2025.
  • Moreover, its 3-year median value for EBIT was $14.4 million (2024), whereas its average is $40.6 million.
  • Over the last 5 years, Calumet's EBIT had its largest YoY gain of 66549.91% in 2025, and its largest YoY loss of 172903.23% in 2025.
  • Calumet's EBIT (Quarter) stood at -$13.9 million in 2023, then surged by 263.31% to $22.7 million in 2024, then surged by 1322.47% to $322.9 million in 2025.
  • Its last three reported values are $322.9 million in Q3 2025, -$101.0 million for Q2 2025, and -$48.7 million during Q1 2025.